-
1
1787 evaluation of transperineal prostatic administration of a PSA-activasted protoxin (PRX302) in men with luts secondary to BPH
Published 2010“…The IPSS still showed a decrease of 4.3 points at 2 years post-treatment. However, no clear dose response was observed and Qmax did not increase in this study. …”
Get full text
Get full text
Get full text
Get full text
article